![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
Fleming Laboratories Limited plans to establish a new Bulk Drugs and Intermediates Project in Usirikapally, Telangana. The project is in the advanced phases of planning, and completion is anticipated between 18 and 24 months after construction commences. The Bulk Drugs & Intermediates Project will produce a variety of bulk drugs and intermediates, including antibiotics, anti-inflammatory drugs, and anti-cancer drugs, with a capacity of 3.7 tpm and a cost of 55 crores.
The endeavour is anticipated to generate approximately 175 permanent and temporary employment opportunities. All necessary environmental and regulatory clearances have been granted. Additionally, Fleming Laboratories Limited has secured the required funding for the initiative.
The Bulk Drugs & Intermediates Project is an important development for Telangana's pharmaceutical industry and is anticipated to attract additional API manufacturers to the state. Here are some of the key benefits of the Bulk Drugs & Intermediates Project: It will help to reduce India's dependence on imported bulk drugs and intermediates. It will create employment opportunities in Telangana. It will contribute to the growth of the pharmaceutical industry in Telangana. It will attract other API manufacturers to the state.
As of September 2023, The project is now in the stage of construction being started the work on the project will be finished in 2024, 2025 or 2026 It has been decided to hire a local contractor.
News by Rahul Yeligetti
